Dual therapy stent
|Dual Therapy Stent|
The Combo Dual Therapy Stent (OrbusNeich)
A dual therapy stent is a coronary artery stent that combines the technology of a bioengineered stent and a drug eluting stent to both accelerate endothelial coverage (healing of the vessel) and to block cell proliferation, thereby reducing the risk of restenosis.
The Combo Dual Therapy Stent (OrbusNeich) is the only dual therapy stent available today. It combines the Genous endothelial progenitor cell capture technology with an antiproliferative, biodegradable sirolimus drug elution. The Combo Stent has received CE Mark approval in Europe and was shown to be as effective as a paclitaxel-eluting stent in controlling neointimal hyperplasia.
- Dual-Therapy Stenting: The Next Step in the Evolution of Stent Design (Cardiology Today: Intervention)
- London, Susan (14 November 2011). "Bioengineered, Sirolimus-Eluting Stent Found ‘Safe,’ and ‘Effective.’" Cardiology News.
- First Dual-Therapy Stent Nets CE Mark (Cardiology Today’s Intervention)
- TCT: Combo Stent Comparable to Taxus (MedPage Today)
|This biotechnology article is a stub. You can help Wikipedia by expanding it.|